Drugs to be Discontinued

Metadata Updated: November 10, 2020

Companies are required under Section 506C of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (as amended by the Food and Drug Administration Safety and Innovation Act) to notify FDA of a permanent discontinuance of certain drug products, six months in advance, or if that is not possible, as soon as practicable. These drugs include those that are life-supporting, life-sustaining or for use in the prevention or treatment of a debilitating disease or condition, including any such drug used in emergency medical care or during surgery). The discontinuations provided below reflect information received from manufacturers, and are for informational purposes only.

Access & Use Information

Public: This dataset is intended for public access and use. License: See this page for license information.

Downloads & Resources

Dates

Metadata Created Date November 10, 2020
Metadata Updated Date November 10, 2020

Metadata Source

Harvested from Healthdata.gov

Additional Metadata

Resource Type Dataset
Metadata Created Date November 10, 2020
Metadata Updated Date November 10, 2020
Publisher Department of Health & Human Services
Unique Identifier Unknown
Maintainer
Identifier 642e816a-6a55-492c-a29f-1b7abf5f2fa5
Data First Published 2014-01-09
Data Last Modified 2016-09-02
Public Access Level public
Bureau Code 009:10
Metadata Context https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld
Metadata Catalog ID https://healthdata.gov/data.json
Schema Version https://project-open-data.cio.gov/v1.1/schema
Catalog Describedby https://project-open-data.cio.gov/v1.1/schema/catalog.json
Homepage URL https://healthdata.gov/dataset/drugs-be-discontinued-0
License https://opendatacommons.org/licenses/odbl/1.0/
Program Code 009:002
Source Datajson Identifier True
Source Hash e2a463c7b5537d8fa6a96520eef50a7305bcba94
Source Schema Version 1.1

Didn't find what you're looking for? Suggest a dataset here.